Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced that management will participate in a fireside chat at the H.C. Wainwright Cell Therapy Virtual Conference on Tuesday, February 28, 2023, at 1:00 p.m. ET. A live webcast of this discussion will be accessible from Arcellx’s website at in the Investors section. A replay of the webcast will be archived and available for 30 days following the event. About ArcellxArcellx, Inc. is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherap(…) Read More ยป